Lin et al.’s study demonstrated that all 16 NPC patients who received autologous DC vaccines stimulated by LMP2 antigens generated EBV-specific CD8+ T-cell responses, with two patients showing significant tumor regression [204] (Table 2). The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.